Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, active pancreatitis, or severe kidney or liver disease should avoid this medication
Results Description of the Included Studies and the Study Characteristics After identification, screening, and data extraction, 100 studies were included for the systematic review
Results vary, but clinical trials show many people lose 1520% or more of their starting body weight with sustained tirzepatide treatment
Some may move up more quickly, while others stay at a lower dose and still see great results
Very low blood sugar can lead to seizures, passing out, long lasting brain damage, and sometimes death
US$ 27.09
US$ 23.66
US$ 21.11
US$ 27.83
US$ 28.58
